Top

Published in:

Open Access 01-12-2022 | Research article

Association of ideal cardiovascular health with cardiovascular events and risk advancement periods in a Mediterranean population-based cohort

Authors: Cesar I. Fernandez-Lazaro, Carmen Sayon-Orea, Estefania Toledo, Conchi Moreno-Iribas, María J. Guembe, for the RIVANA Study Investigators

Published in: BMC Medicine | Issue 1/2022

Abstract

Background

The American Heart Association recommends Life’s Simple 7 as ideal cardiovascular health (ICVH) to reduce cardiovascular risk. Rate advancement period (RAP), a useful tool to quantify and communicate exposure impact on risks, may enhance communication about the benefits of achieving ICVH. We aimed to examine whether greater adherence to ICVH metrics was associated with reduced incidence of cardiovascular risk in a population-based cohort and estimate its impact on the timing of occurrence using RAP.

Methods

Prospective analyses of 3826 participants, initially free from cardiovascular disease at baseline, enrolled in the Vascular Risk in Navarra Study (RIVANA), a Mediterranean population-based cohort of Spanish adults. ICVH metrics were defined using participants’ baseline information as follows: never-smoker or quitting > 12 months ago, body mass index < 25 kg/m², ≥ 150 min/week of moderate physical activity or equivalent, healthy dietary pattern (≥ 9 points on a validated 14-item Mediterranean diet adherence screener), untreated cholesterol < 200 mg/dL, untreated blood pressure < 120/80 mmHg, and untreated fasting blood glucose < 100 mg/dL. Participants were assigned 1 point for each achieved metric and were grouped according to their number of accumulated metrics in ≤ 2, 3, 4, and ≥ 5. The primary endpoint was major cardiovascular events (composite of myocardial infarction, stroke, or death from cardiovascular causes). Cox proportional hazard ratios (HRs) and RAPs with their corresponding 95% confidence intervals (95% CI) adjusted for potential confounders were calculated.

Results

During a median follow-up of 12.8 years (interquartile range 12.3–13.1), a total of 194 primary endpoints were identified. Compared to participants with ≤ 2 ideal metrics, HR (95% CI) for major cardiovascular events among participants meeting ≥ 5 metrics was 0.32 (0.17–0.60) with RAP (95% CI) of − 14.4 years (− 22.9, − 5.9).

Conclusions

Greater adherence to ICVH metrics was associated with lower cardiovascular risk among Spanish adults of the RIVANA cohort. Adherence to ideal metrics may substantially delay cardiovascular risk.

Available only for authorised users

Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics-2021 update a report from the American Heart Association. Circulation. 2021;143:E254–743. https://doi.org/10.1161/CIR.0000000000000950.CrossRefPubMed

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010.CrossRefPubMedPubMedCentral

Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, et al. European cardiovascular disease statistics 2017. Brussels: European Heart Network; 2017.

Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395:795–808. https://doi.org/10.1016/S0140-6736(19)32008-2.CrossRefPubMed

Patel SA, Winkel M, Ali MK, Narayan KMV, Mehta NK. Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med. 2015;163:245–53. https://doi.org/10.7326/M14-1753.CrossRefPubMed

Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121:586–613. https://doi.org/10.1161/CIRCULATIONAHA.109.192703.CrossRefPubMed

Fang N, Jiang M, Fan Y. Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: a meta-analysis. Int J Cardiol. 2016;214:279–83. https://doi.org/10.1016/j.ijcard.2016.03.210.CrossRefPubMed

Aneni EC, Crippa A, Osondu CU, Valero-Elizondo J, Younus A, Nasir K, et al. Estimates of mortality benefit from ideal cardiovascular health metrics: a dose response meta-analysis. J Am Heart Assoc. 2017;6:e006904. https://doi.org/10.1161/JAHA.117.006904.CrossRefPubMedPubMedCentral

Younus A, Aneni EC, Spatz ES, Osondu CU, Roberson L, Ogunmoroti O, et al. A systematic review of the prevalence and outcomes of ideal cardiovascular health in US and non-US populations. Mayo Clin Proc. 2016;91:649–70. https://doi.org/10.1016/j.mayocp.2016.01.019.CrossRefPubMed

10.

Navar AM, Wang TY, Mi X, Robinson JG, Virani SS, Roger VL, et al. Influence of cardiovascular risk communication tools and presentation formats on patient perceptions and preferences. JAMA Cardiol 2018;3:1192–1199. doi:https://doi.org/10.1001/JAMACARDIO.2018.3680.

11.

Mentrup S, Harris E, Gomersall T, Köpke S, Astin F. Patients’ experiences of cardiovascular health education and risk communication: a qualitative synthesis. Qual Health Res. 2020;30:88–104. https://doi.org/10.1177/1049732319887949.CrossRefPubMed

12.

Waldron CA, van der Weijden T, Ludt S, Gallacher J, Elwyn G. What are effective strategies to communicate cardiovascular risk information to patients? A systematic review. Patient Educ Couns. 2011;82:169–81. https://doi.org/10.1016/J.PEC.2010.04.014.CrossRefPubMed

13.

Brenner H, Gefeller O, Greenland S. Risk and rate advancement periods as measures of exposure impact on the occurrence of chronic diseases. Epidemiology. 1993;4:229–36. https://doi.org/10.1097/00001648-199305000-00006.CrossRefPubMed

14.

Discacciati A, Andrea B, Nicola O, Sander G. On the interpretation of risk and rate advancement periods. Int J Epidemiol. 2016;45:278–84. https://doi.org/10.1093/ije/dyv320.CrossRefPubMed

15.

Liese AD, Hense H-W, Brenner H, Löwel H, Keil U. Assessing the Impact of classical risk factors on myocardial infarction by rate advancement periods. Am J Epidemiol. 2000;152:884–8. https://doi.org/10.1093/aje/152.9.884.CrossRefPubMed

16.

Ordóñez-Mena JM, Schöttker B, Mons U, Jenab M, Freisling H, Bueno-de-Mesquita B, et al. Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium. BMC Med. 2016;14:27. https://doi.org/10.1186/s12916-016-0607-5.CrossRef

17.

Ford ES, Zhao G, Tsai J, Li C. Low-risk lifestyle behaviors and all-cause mortality: findings from the national health and nutrition examination survey III mortality study. Am J Public Health. 2011;101:1922–9. https://doi.org/10.2105/AJPH.2011.300167.CrossRefPubMedPubMedCentral

18.

Fresán U, Martínez-González MA, Sabaté J, Bes-Rastrollo M, Angel Martínez-González M, Sabaté J, et al. Global sustainability (health, environment and monetary costs) of three dietary patterns: results from a Spanish cohort (the SUN project). BMJ Open. 2019;9:e021541.CrossRef

19.

Díez-Espino J, Buil-Cosiales P, Babio N, Toledo E, Corella D, Ros E, et al. Impact of Life’s Simple 7 on the incidence of major cardiovascular events in high-risk Spanish adults in the PREDIMED study cohort. Rev Esp Cardiol (Engl Ed). 2020;73:205–11. https://doi.org/10.1016/j.rec.2019.05.010.CrossRef

20.

Martínez-González MÁ, Corella D, Salas-Salvadó J, Ros E, Covas MI, Fiol M, et al. Cohort profile: design and methods of the PREDIMED study. Int J Epidemiol. 2012;41:377–85. https://doi.org/10.1093/ije/dyq250.CrossRefPubMed

21.

Fernández-Lázaro CI, Ruiz-Canela M, Martínez-González MÁ. Deep dive to the secrets of the PREDIMED trial. Curr Opin Lipidol. 2021;32:62–9. https://doi.org/10.1097/MOL.0000000000000731.CrossRefPubMed

22.

Viñes JJ, Díez J, Guembe MJ, González P, Amézqueta C, Barba J, et al. Estudio de Riesgo Vascular en Navarra: Objetivos y Diseño. Prevalencia del Síndrome Metabólico y de los Factores Mayores de Riesgo Vascular [Study of vascular risk in Navarre: objectives and design. Prevalence of metabolic syndrome and of vascular risk factors]. An Sist Sanit Navar. 2007;30:113–24.PubMed

23.

Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, Toledo E, Moreno-Iribas C. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 2020;19:195. https://doi.org/10.1186/s12933-020-01166-6.CrossRefPubMedPubMedCentral

24.

Schröder H, Fitó M, Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, et al. A short screener is valid for assessing mediterranean diet adherence among older Spanish men and women. J Nutr. 2011;141:1140–5. https://doi.org/10.3945/jn.110.135566.CrossRefPubMed

25.

Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Covas MI, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors a randomized trial. Ann Intern Med. 2006;145:1–11. https://doi.org/10.7326/0003-4819-145-1-200607040-00004.CrossRefPubMed

26.

Elosua R, Marrugat J, Molina L, Pons S, Pujol E. Validation of the Minnesota leisure time physical activity questionnaire in Spanish men. Am J Epidemiol. 1994;139:1197–209. https://doi.org/10.1093/oxfordjournals.aje.a116966.CrossRefPubMed

27.

Elosua R, Garcia M, Aguilar A, Molina L, Covas MIM-I, Marrugat J. Validation of the Minnesota leisure time physical activity questionnaire in Spanish women. Med Sci Sport Exerc. 2000;32:1431–7. https://doi.org/10.1097/00005768-200008000-00011.CrossRef

28.

Ainsworth BE, Haskell W, Leon A, David DR, Jacobs J, Montoye H, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sport Exerc. 1993;25:71–80. https://doi.org/10.1249/00005768-199301000-00011.CrossRef

29.

WHO guidelines on physical activity and sedentary behaviour. Geneva: World Health Organization; 2020. https://apps.who.int/iris/bitstream/handle/10665/336656/9789240015128-eng.pdf?sequence=1&isAllowed=y. Accessed 17 Jan 2021.

30.

Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR, Tudor-Locke C, et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43:1575–81.CrossRef

31.

Kaminsky LA, Montoye AHK. Physical activity and health: what is the best dose? J Am Heart Assoc. 2014;3:e001430.CrossRef

32.

Martínez-González MA, Gea A, Ruiz-Canela M. The Mediterranean diet and cardiovascular health. Circ Res. 2019;124:779–98.CrossRef

33.

Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378:e34. https://doi.org/10.1056/NEJMoa1800389.CrossRefPubMed

34.

Hu EA, Toledo E, Diez-Espino J, Estruch R, Corella D, Salas-Salvado J, et al. Lifestyles and risk factors associated with adherence to the Mediterranean diet: a baseline assessment of the PREDIMED trial. PLoS One. 2013;8:e60166. https://doi.org/10.1371/journal.pone.0060166.CrossRefPubMedPubMedCentral

35.

Cano-Ibáñez N, Bueno-Cavanillas A, Martínez-González MÁ, Salas-Salvadó J, Corella D, Freixer GL, et al. Effect of changes in adherence to Mediterranean diet on nutrient density after 1-year of follow-up: results from the PREDIMED-Plus study. Eur J Nutr. 2019;59. https://doi.org/10.1007/s00394-019-02087-1.

36.

Sayon-Orea C, Moreno-Iribas C, Delfrade J, Sanchez-Echenique M, Amiano P, Ardanaz E, et al. Inverse-probability weighting and multiple imputation for evaluating selection bias in the estimation of childhood obesity prevalence using data from electronic health records. BMC Med Inform Decis Mak. 2020;20:9. https://doi.org/10.1186/s12911-020-1020-8.CrossRefPubMedPubMedCentral

37.

Moreno-Iribas C, Sayon-Orea C, Delfrade J, Ardanaz E, Gorricho J, Burgui R, et al. Validity of type 2 diabetes diagnosis in a population-based electronic health record database. BMC Med Inform Decis Mak. 2017;17:34. https://doi.org/10.1186/s12911-017-0439-z.CrossRefPubMedPubMedCentral

38.

Hernan MA, Robins JM. Causal inference: what if. Boca Raton: Chapman & Hall/CRC; 2020.

39.

Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29:n/a. https://doi.org/10.1002/sim.3841.CrossRef

40.

Royston P, Lambert PC. Flexible parametric survival analysis using Stata: beyond the Cox model. 1st ed. College Station: Stata Press; 2011.

41.

Graciani A, León-Muñoz LM, Guallar-Castillón P, Rodríguez-Artalejo F, Banegas JR. Cardiovascular health in a southern Mediterranean European country. Circ Cardiovasc Qual Outcomes. 2013;6:90–8. https://doi.org/10.1161/CIRCOUTCOMES.112.967893.CrossRefPubMed

42.

Instituto Nacional de Estadística [National Statistics Institute of Spain]. Ejercicio físico regular y sedentarismo en el tiempo libre [Leisure time physical activity and sedentarism]; 2020. https://www.ine.es/ss/Satellite?L=es_ES&c=INESeccion_C&cid=1259944495973&p=1254735110672&pagename=ProductosYServicios%2FPYSLayout&param1=PYSDetalleFichaIndicador&param3=1259937499084#:~:text=Seg%C3%BAn%20la%20Encuesta%20Europea%20de,porcentaje%20de%2025%2C9%25. Accessed 8 Feb 2022.

43.

Li Y, Schoufour J, Wang DD, Dhana K, Pan A, Liu X, et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. BMJ. 2020;368. https://doi.org/10.1136/bmj.l6669.

44.

Naik G, Ahmed H, Edwards AGK. Communicating risk to patients and the public. Br J Gen Pract. 2012;62:213. https://doi.org/10.3399/BJGP12X636236.CrossRefPubMedPubMedCentral

Title: Association of ideal cardiovascular health with cardiovascular events and risk advancement periods in a Mediterranean population-based cohort
Authors: Cesar I. Fernandez-Lazaro
Carmen Sayon-Orea
Estefania Toledo
Conchi Moreno-Iribas
María J. Guembe
for the RIVANA Study Investigators
Publication date: 01-12-2022
Publisher: BioMed Central
Published in: BMC Medicine / Issue 1/2022
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-022-02417-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Association of ideal cardiovascular health with cardiovascular events and risk advancement periods in a Mediterranean population-based cohort

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Lower gestational age is associated with lower cortical volume and cognitive and educational performance in adolescence

Correction: A genome-wide association study identifies a novel association between SDC3 and apparent treatment-resistant hypertension

Human placental proteomics and exon variant studies link AAT/SERPINA1 with spontaneous preterm birth

Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events

Imagery ability assessments: a cross-disciplinary systematic review and quality evaluation of psychometric properties

Biological aging mediates the associations between urinary metals and osteoarthritis among U.S. adults